iCAD to Present at the Cantor Fitzgerald Global Healthcare Conference
Get Alerts ICAD Hot Sheet
Join SI Premium – FREE
NASHUA, N.H., Sept. 20, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that management will be providing a corporate update at the Cantor Fitzgerald Global Healthcare Conference, being held September 25-27 in New York City.
Presentation DetailsDate: Tuesday, September 26Time: 4:35pm Eastern TimeLocation: InterContinental New York Barclay Hotel, Empire Ballroom 1Webcast: http://wsw.com/webcast/cantor6/icad
About iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked for use anywhere in the body, including treatment of nonmelanoma skin cancer, early-stage breast cancer and gynecological cancers. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. For more information, visit or www.icadmed.com or www.xoftinc.com.
CONTACT: For iCAD investor relations:LifeSci AdvisorsBob Yedid, (646)-597-6989[email protected]
or
For iCAD media inquiries:Berry & Company Public Relations, LLCLynn Granito, 212-253-8881[email protected]
Source: Icad IncSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Solana Price Prediction 2026: What Would $500 Require as Remittix Advances Toward Its $0.46 Final Presale Stage?
- Velox Pickleball Expands Wholesale Program to Meet Growing Retail Demand for Premium Paddles
- XRP Price Prediction: Binance XRP Inflows Jump 663% but Almost None Gets Sold as AlphaPepe Listing Buzz Builds
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Cantor Fitzgerald, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share